Flexible robotic ‘mini surgeon’ set to ease hysterectomies
Flexible robotic ‘mini surgeon’ set to ease hysterectomies
Memic Innovative Surgery raises $96m, receives FDA authorization for Hominis system to be used in laparoscopic transvaginal benign procedures.
Hominis, the surgical robot that acts like a surgeon’s arm
An estimated 600,000 American women have hysterectomies every year to treat a variety of non-cancerous conditions.
And although the American Congress of Obstetricians and Gynecologists recommends transvaginal – rather than abdominal hysterectomy as the safest, least invasive and most cost-effective approach with the fastest recovery time, only 15 to 20 percent of uterus removals are done this way.
Memic raises $96 million to commercialize FDA-approved robotic arm timesofisrael.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from timesofisrael.com Daily Mail and Mail on Sunday newspapers.
The Hominis Surgical System developed by Memic Innovative Surgery is a robotic surgical device (Courtesy)
Memic Innovative Surgery, a medical device company, said it has received marketing authorization from the US Food and Drug Administration for a robotic surgical device it has developed to perform transvaginal hysterectomies in patients.
The Hominis Surgical System developed by Memic features miniature humanoid-shaped robotic arms. It is intended for benign hysterectomy, or the removal of the uterus for non-cancerous conditions along with the removal of one or both fallopian tubes and ovaries.
“We are providing physicians and patients another minimally-invasive gynecologic surgical option for non-cancerous conditions,” said Dr. Binita Ashar, director of the Office of Surgical and Infection Control Devices in the FDA’s Center for Devices and Radiological Health, in a statement on March 1. “The FDA continues to support advancements in safe and effective medical devices th